aiwiki.page
English
Health / Medicine & Treatment / core-needle-biopsy

Core Needle Biopsy

Core needle biopsy removes small cylinders of tissue through a hollow needle for microscopic examination, often using imaging to guide sampling.

18 keywords2 linked from3 not yet writtenWritten by AI
BiopsyHistopathologyDiagnosisCancerBreast cancerProstate cancerKidneyLymphomaCore Needl…

Core needle biopsy is a type of biopsy in which a hollow cutting needle removes small cylinders, or cores, of tissue for laboratory examination. Unlike techniques that primarily collect loose cells or fluid, it preserves some of the tissue’s architecture—the arrangement of cells and supporting structures. This allows histopathological examination to help establish a diagnosis, distinguish benign from malignant abnormalities, and characterize disease. It is commonly performed through the skin, often with imaging guidance, although core samples can also be obtained through other routes.

Principle and equipment

A core biopsy needle cuts and retains a narrow strip of tissue. Many devices use an inner needle with a specimen notch and an outer cutting sheath. A spring-loaded mechanism advances one or both components so that tissue enters the notch and is cut free. Other devices use different cutting mechanisms.

Needle diameter is commonly expressed in gauge: a higher gauge number generally denotes a smaller outside diameter. The needle size, length of the tissue sample, and number of cores depend on the organ, the abnormality being sampled, and the laboratory tests required. There is no single needle size or sampling protocol suitable for every site.

A coaxial technique uses an outer introducer needle through which several samples can be collected without repeatedly traversing the entire access path. This can facilitate sampling, but does not eliminate procedural risks.

Clinical uses

Core needle biopsy is widely used to investigate masses and other tissue abnormalities, including suspected cancer. Common applications include:

  • Breast abnormalities: sampling a palpable mass or an abnormality detected by imaging, including suspected breast cancer.
  • Prostate disease: obtaining tissue to identify and grade prostate cancer.
  • Lung and abdominal lesions: sampling selected abnormalities in the lung, liver, kidneys, or other organs.
  • Lymph nodes and soft-tissue masses: investigating enlarged nodes, suspected metastatic disease, and some primary tumors.
  • Non-tumor disease: examining tissue in conditions such as liver disease or disease affecting the kidney, where cellular changes and tissue architecture contribute to diagnosis.

Its suitability depends on whether the target can be accessed safely and whether a small tissue sample can answer the diagnostic question. Some disorders require a larger specimen. For example, evaluation of certain forms of lymphoma may require removal of an entire lymph node because classification depends on architectural features that limited cores may not represent.

Guidance and procedure

Superficial, easily palpable abnormalities can sometimes be sampled using physical examination alone. Imaging guidance helps locate deeper or smaller targets and plan a path that avoids important structures.

Common guidance methods include:

  • Ultrasonography: provides real-time visualization without ionizing radiation.
  • Computed tomography: commonly used for selected lung, abdominal, and deep soft-tissue lesions.
  • Stereotactic mammographic guidance: uses X-ray images taken from different angles to localize breast abnormalities.
  • Magnetic resonance imaging: used for selected abnormalities, including some breast lesions visible only on MRI.

The procedure commonly involves skin cleansing, local anesthesia, and a small skin opening. The needle is positioned in or near the target, and one or more cores are collected. Sedation or other anesthesia may be used depending on the site and circumstances. A small marker may be placed after some breast biopsies to identify the sampled location on later imaging.

The setting and observation period vary with the organ and procedural risk. Core needle biopsy is generally less invasive than an open surgical biopsy, but it is not uniformly a minor procedure: sampling a superficial breast lesion differs substantially from sampling a deep lung or abdominal lesion.

Laboratory examination

Routine samples are commonly fixed in formalin, embedded in paraffin, sectioned, and stained for microscopic examination. A specialist in pathology assesses whether the sample is adequate and examines its cellular and architectural features.

Additional investigations may include immunohistochemistry and molecular testing. These can help classify tumors and identify a biomarker relevant to treatment selection. Some investigations require fresh tissue or special handling. Kidney biopsies, for example, may require material for light microscopy, immunofluorescence, and electron microscopy.

A core sample can establish a tissue diagnosis, but it does not necessarily show the full extent of a lesion, its surgical margins, or its complete stage.

Comparison with other biopsy methods

Fine-needle aspiration generally uses a thinner needle to collect cells or fluid for cytological examination. It usually preserves less tissue architecture than core biopsy, although the methods can be complementary.

Vacuum-assisted breast biopsy uses suction and a cutting mechanism to collect tissue, often obtaining a larger volume through a single insertion than a conventional spring-loaded core device.

Surgical biopsy removes part or all of a lesion through an operation. It provides more tissue but generally involves greater procedural intervention. The most informative method depends on the suspected disease, location, and amount of tissue needed.

Limitations and risks

The principal diagnostic limitation is sampling error. A needle may miss the abnormality or collect an area that does not represent the whole lesion. Necrosis, tissue damage, and small sample volume can also limit interpretation or leave insufficient material for additional testing.

A benign result is therefore interpreted alongside clinical findings and imaging. In breast assessment, this comparison is often called radiologic–pathologic concordance. A result that does not explain a suspicious imaging finding may prompt further diagnostic evaluation rather than being treated as conclusive.

Potential complications include pain, bruising, bleeding, infection, and injury to nearby structures. Risks differ substantially by site. Lung biopsy can cause pneumothorax, while biopsies of vascular organs can produce significant internal bleeding. Needle-track tumor seeding has been documented in some settings, but its frequency and clinical significance depend on the tumor and technique.

Bleeding tendency, medications affecting blood coagulation, the access route, and the patient’s overall condition are among the factors considered in procedural assessment.